NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.60M | -16.09M | -5.38M | -33.61M | -33.18M |
| Total Depreciation and Amortization | 332.00K | 326.00K | 326.00K | 300.00K | 300.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.47M | 9.64M | -1.25M | 24.95M | 27.33M |
| Change in Net Operating Assets | 1.65M | 123.00K | 2.28M | 1.42M | 985.00K |
| Cash from Operations | -3.90M | -6.00M | -4.03M | -6.94M | -4.57M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 35.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.00K | -15.00K | -- | -18.00K | 0.00 |
| Cash from Investing | -17.00K | -15.00K | 35.00K | -18.00K | 0.00 |
| Total Debt Issued | 2.74M | 8.29M | 1.47M | 60.00K | 12.79M |
| Total Debt Repaid | -2.13M | -- | -- | -300.00K | -- |
| Issuance of Common Stock | 349.00K | -- | -- | 1.00K | 1.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.86M | -2.23M | 2.53M | -1.56M | -2.33M |
| Cash from Financing | 3.82M | 6.06M | 4.01M | -1.80M | 12.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.00K | 45.00K | 8.00K | -8.76M | 7.56M |